The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $119.06

Today's change-1.06 -0.88%
Updated October 19 4:00 PM EDT. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $119.06

Today's change-1.06 -0.88%
Updated October 19 4:00 PM EDT. Delayed by at least 15 minutes.

United Therapeutics Corp down (U.S.)$1.06

United Therapeutics Corp closed lower Thursday, dropping (U.S.)$1.06 or 0.88% to (U.S.)$119.06. Over the last five days, shares have lost 1.01% and are down 16.99% for the last year to date. This security has underperformed the S&P 500 by 17.27% during the last year.

Key company metrics

  • Open(U.S.) $120.15
  • Previous close(U.S.) $120.12
  • High(U.S.) $120.15
  • Low(U.S.) $118.00
  • Bid / Ask-- / --
  • YTD % change-16.99%
  • Volume432,384
  • Average volume (10-day)316,381
  • Average volume (1-month)489,193
  • Average volume (3-month)537,392
  • 52-week range(U.S.) $110.90 to (U.S.) $169.89
  • Beta1.38
  • Trailing P/E13.88×
  • P/E 1 year forward11.12×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $8.58
Updated October 19 4:00 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue445371409408
Total other revenue--------
Total revenue445371409408
Gross profit426356381385
Total cost of revenue19142824
Total operating expense403107235170
Selling / general / administrative6756140100
Research & development60366746
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)257------
Other operating expenses, total--------
Operating income42264174239
Interest income (expense), net non-operating-1-1-2-1
Gain (loss) on sale of assets----00
Other--------
Income before tax44264172239
Income after tax-56179110162
Income tax, total100856177
Net income-56179110162
Total adjustments to net income--------
Net income before extra. items-56179110162
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-56179110162
Inc. avail. to common incl. extra. items-56179110162
Diluted net income-56179110162
Dilution adjustment--------
Diluted weighted average shares45464546
Diluted EPS excluding extraordinary itemsvalue per share-1.253.892.433.50
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share2.473.892.433.50